2010 Q1/Global Life Sciences



Changes in rank are compared to 2009 Q4/Global Life Sciences. Since then, 2 sites entered the survey and 11 sites could not be included in the rankings (1 more since last time).

Details

Scores

Percentage Failures




Rank Name Exact overall
same Neurimmune Therapeutics AG 8.84
same Lipideon Biotechnology AG 8.40
+ 57 Medinova AG 8.11
+ 48 OMIDA AG 7.66
- 1 Nycomed Pharma AG 7.47
+ 2 AmVac AG 7.45
- 2 Helsinn Healthcare S.A. 7.31
+ 2 Newron 7.15
- 2 Alpex Pharma SA 7.08
+ 2 ArisGen SA 7.03
same Siegfried AG 6.95
- 3 BioPartners GmbH 6.86
+ 6 Axenoll AG 6.85
+ 9 4-Antibody AG 6.84
- 1 Biogen Idec International GmbH 6.82
- 10 Arpida AG 6.51
- 2 Kuros Biosurgery AG 6.49
+ 24 AC Immune SA 6.46
+ 13 Johnson & Johnson Pharmaceutical Research & Development 6.42
- 3 Tricom GmbH, Pharma Division 6.32
same BioVersys GmbH 6.27
+ 11 Cytos Biotechnology AG 6.05
+ 2 Helvepharm AG 6.02
- 11 Evolva SA 5.99
+ 2 Galenica Ltd. 5.92
+ 2 Anavex Life Sciences Corp. 5.90
+ 2 Auris Medical AG 5.87
+ 2 Max Zeller Söhne AG 5.86
+ 2 GKL Biotec AG 5.84
+ 32 Basilea Pharmaceutica Ltd. 5.71
+ 3 Neurotune 5.67
+ 3 Med Discovery S.A. 5.67
- 9 Vifor (International) Ltd. 5.56
+ 2 CSL Behring AG 5.56
+ 2 Actelion Ltd. 5.46
+ 8 Novartis International AG 5.36
+ 2 Addex Pharmaceuticals 5.15
same Ferring International Center SA 4.94
+ 1 Aurora Pharma GmbH 4.87
+ 3 Lunamed AG 4.83
+ 9 F. Hoffmann-La Roche AG Switzerland 4.79
- 16 Covagen AG 4.71
- 23 GlycoVaxyn AG 4.70
- 22 Merck Serono International SA 4.62
same Bayer Schweiz AG 4.61
+ 1 Crucell | Berna Biotech Ltd 4.48
new Valeant Pharmaceuticals Switzerland GmbH 4.37
+ 1 Medipol SA 4.31
+ 4 Ergonex Pharma GmbH 4.22
- 4 Gruenenthal Pharma AG 4.20
- 10 Nitec Pharma AG 4.15
+ 5 AstraZeneca AG 4.12
+ 6 Novartis Pharma Schweiz AG 4.12
+ 1 Spirig Pharma AG 4.10
- 39 PharmaSwiss SA - HQ 4.08
same 3-V Biosciences GmbH 4.03
- 3 Debiopharm S.A. 3.96
same NovImmune 3.90
+ 8 Neurim Pharmaceuticals S.A. 3.89
- 12 GeNeuro SA 3.68
+ 5 Permamed AG 3.61
+ 2 Kenta Biotech AG 3.58
same Octapharma AG 3.54
+ 5 Antares Pharma AG 3.46
- 4 F. Hoffmann-La Roche AG Global 3.40
+ 2 Merck Sharp & Dohme-Chibret AG 3.29
new Solvay Pharma AG 3.24
- 3 Nycomed International Management GmbH 3.17
+ 1 ESBATECH AG 3.04
+ 3 mondoBIOTECH AG 2.95
+ 4 Baxter Switzerland 2.92
- 1 Schwabe Pharma AG 2.89
- 1 Streuli Pharma AG 2.78
same Mepha Pharma AG 2.63
+ 1 Cryo-Save AG 2.60
+ 1 GenKyoTex SA 2.53
+ 1 OM PHARMA 2.36